Compare RENT & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RENT | ANIK |
|---|---|---|
| Founded | 2009 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.3M | 191.4M |
| IPO Year | 2021 | 1996 |
| Metric | RENT | ANIK |
|---|---|---|
| Price | $5.65 | $15.33 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 87.3K | ★ 111.0K |
| Earning Date | 04-14-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 110.16 | 80.16 |
| EPS | ★ 1.88 | N/A |
| Revenue | ★ $329,800,000.00 | $112,819,000.00 |
| Revenue This Year | N/A | $5.98 |
| Revenue Next Year | $2.72 | $7.42 |
| P/E Ratio | $2.80 | ★ N/A |
| Revenue Growth | ★ 7.71 | N/A |
| 52 Week Low | $3.69 | $7.90 |
| 52 Week High | $10.13 | $15.58 |
| Indicator | RENT | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 56.00 | 65.61 |
| Support Level | $4.27 | $13.81 |
| Resistance Level | $6.33 | N/A |
| Average True Range (ATR) | 0.64 | 0.54 |
| MACD | 0.11 | -0.04 |
| Stochastic Oscillator | 38.04 | 87.13 |
Rent the Runway Inc is an e-commerce platform that allows users to rent, subscribe to, or buy designer apparel and accessories. The company gives customers access to its unlimited closet through its subscription offering (Subscription) or the ability to rent a-la-carte through its reserve offering (Reserve). The company also gives its subscribers and customers the ability to buy its products through its Resale offering. The Closet in the Cloud offers a wide assortment of items for every occasion, from evening wear and accessories to ready-to-wear, workwear, denim, casual, maternity, outerwear, blouses, knitwear, loungewear, jewelry, handbags, activewear, and ski wear.
Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.